Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market By Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), By Delivery Platform (Rapid Exchange (RX) / Monorail ba

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market By Product (Normal balloon catheter, Drug eluting balloon catheter, Cutting balloon catheter, Scoring balloon catheter), By Delivery Platform (Rapid Exchange (RX) / Monorail balloon catheter, Over-the-wire (OTW) balloon catheter), By Compliance (Semi-Compliant, Non-Compliant), By Balloon Material (Polyolefin copolymer (POC), Polyethylene (PE), Polyethylene terephthalate (PET)): Global Opportunity Analysis and Industry Forecast, 2021-2031

The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheters market was estimated to be $1,201.23 million in 2021 and is estimated to reach $1,848.76 million in 2031 with an expected CAGR of 4.4% from 2022 to 2031. A PTCA balloon catheter is a device having a balloon at the tip that may be inflated or deflated while in place to open, widen, or close a route. These are employed in surgical procedures, with the most common applications being coronary artery disease and stent placement. Increase in occurrences of cardiac disorder, surge in geriatric population, attractive reimbursement policies, and technical improvements are all contributing to the balloon catheter market's expansion.

The market for PTCA balloon catheter is growing, due to increase in frequency of lifestyle-related diseases and surge in geriatric population. This expansion can be ascribed to technology advancements and increase in the number of angioplasty procedures conducted, owing to minimally invasive nature of the surgery. Atherosclerosis can cause peripheral and coronary artery disease, which can lead to stroke, myocardial infarction, and/or cardiovascular mortality. Furthermore, rapid adoption of sophisticated technologies in the angioplasty segment, including as drug-eluting and cutting balloons, is expected to boost market expansion throughout the forecast period, particularly in developed countries. Furthermore, angioplasty balloons have a greater success rate than traditional angioplasty techniques, which is expected to drive market growth.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 as pandemic. The COVID-19 is predicted to have a detrimental impact on market growth. The current COVID-19 situation has resulted in limited population movement in hospitals. People are keen to avoid any form of surgery or diagnostic operations, with the exception of emergencies, to reduce the chance of contracting COVID-19. Furthermore, hospitals have relocated workers from cardiac departments to other departments in need, such as emergency departments or intensive care units (ICU). All of these variables are projected to have an impact on market growth. Nonetheless, this slowdown in growth is projected to be temporary, and the market is expected to rise significantly in the future.

The global PTCA balloon catheter market is segmented on the basis of product, compliance, delivery platform, and balloon material. On the basis of product, it is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Depending on delivery platform, it is bifurcated into over-the-wire and rapid exchange/monorail balloon catheters. As per the compliance, the PTCA balloon catheter market is categorized into semi-compliant and non-compliant. According to balloon material, it is fragmented into polyolefin copolymer (POC), polyethylene (PE) and polyethylene terephthalate (PET). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.

Key players in the value chain include Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Pvt. Ltd., and COOK MEDICAL INC.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the percutaneous transluminal coronary angioplasty (ptca) balloon catheters market analysis from 2021 to 2031 to identify the prevailing percutaneous transluminal coronary angioplasty (ptca) balloon catheters market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the percutaneous transluminal coronary angioplasty (ptca) balloon catheters market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global percutaneous transluminal coronary angioplasty (ptca) balloon catheters market trends, key players, market segments, application areas, and PTCA balloon catheters market opportunity growth strategies.

Key Market Segments


By Product

Normal balloon catheter
Drug eluting balloon catheter
Cutting balloon catheter
Scoring balloon catheter

By Delivery Platform

Rapid Exchange (RX) / Monorail balloon catheter
Over-the-wire (OTW) balloon catheter

By Compliance

Semi-Compliant
Non-Compliant

By Balloon Material

Polyolefin copolymer (POC)
Polyethylene (PE)
Polyethylene terephthalate (PET)

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

ALVI MEDICA
ABOTT LABORATORIES
BOSTON SCIENTIFIC CORPORATION
BECTON, DICKINSON & COMPANY
IVASCULAR
RONSTIS
KONINKLIJKE PHILLIPS
MEDTRONIC PLC
BALTON SP ZOO
B.BRAUN MELSUNGEN AG